Main Article Content

Authors

Introduction: In Colombia, despite the fact that kidney transplants are the most common type of transplant surgery, a great number of transplanted patients do not achieve the desired Human Leucocyte Antigen (hla) compatibility. hla compatibility plays an important role in graft survival; patients with matched-hla have a lower chance of graft-versus-host disease and graft ejection. Objective: To determine the probability of finding an hla-matched donor-recipient pairs according to hla−a, −b and −drb1 frequencies in a specific Colombian population. Materials and methods: The study included a total of 484 unrelated individuals (61 donors and 423 recipients) from the hla registry. hla alleles were determined by polymerase chain reaction sequence with specific indicators. Results: hla–A*02, –A*24, –B*35 and –DRB1*04 alleles showed the highest minimum allele frequency (>10%). In addition, hla–A*24–B*35–DRB1*04 was the most frequent extended haplotype in both donors and recipients (7.38 % and 6.76 %, respectively). Our experimental evidence
showed that the maximum chance of finding at least one hla allele-matched kidney is 20.3 % for a patient with the most frequent extended haplotype, whereas for patients with rare or non-common haplotypes this probability is rather unlikely. Discussion: In terms of probability, the chance of finding an hla matched kidney donor/recipients in our region is low. This is due, at least in part, to the higher number of alleles and a the lower donation rate. Therefore, to define the hla profile of a population is important for establishing transplantation programs and alternative strategies in the kidney donation and allocation processes.

Oscar Flórez, Universidad Industrial de Santander

MSc. Grupo de Inmunología y Epidemiología Molecular, GIEM, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

Carmen C. Cabrales, Universidad Industrial de Santander

Bacteriologist. Grupo de Inmunología y Epidemiología Molecular, GIEM, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

Jenny A. Pinto, Universidad Industrial de Santander

Bacteriologist. Grupo de Inmunología y Epidemiología Molecular, GIEM, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

Gerardo Ramírez, Universidad Industrial de Santander

MD. Grupo de Inmunología y Epidemiología Molecular, GIEM, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.

Julio A. Flórez, Universidad Industrial de Santander

Ing. Escuela de Ingeniería Electrónica, Facultad de Ingenierías Fisicomecánicas, Universidad Industrial de Santander, Bucaramanga, Colombia.

Adolfo Capella, Centro Médico Carlos Ardila Lülle

MD. Nefrólogos Asociados Ltda., Centro Médico Carlos Ardila Lülle, Floridablanca, Colombia.

Clara I. González, Universidad Industrial de Santander

PhD. Grupo de Inmunología y Epidemiología Molecular, GIEM, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Colombia.
Flórez, O., Cabrales, C. C., Pinto, J. A., Ramírez, G., Flórez, J. A., Capella, A., & González, C. I. (2016). HLA-Matched Donor-Recipient Combinations and Kidney Transplant Probabilities in a Specific Colombian Population. Revista Ciencias De La Salud, 14(02), 147–160. https://doi.org/10.12804/revsalud14.02.2016.01

Danovitch GM, Cohen B, Smits JM. Waiting time or wasted time? The case for using time on dialysis to determine waiting time in the allocation of cadaveric kidneys. Am J Transplant 2002;2:891-3.

Kindt TJ, Goldsby RA, Osborne BA, Kuby J. Kuby immunology. New York: W.H. Freeman, 2007: XXII, 574, A-531, G-512, AN-527, I-527.

Choo SY. The HLA system: genetics, immunology, clinical testing, and clinical implications. Yonsei Med J 2007;48:11-23.

Beck S, Trowsdale J. The human major histocompatability complex: lessons from the DNA sequence. Annu Rev Genomics Hum Genet 2000;1:117-37.

Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Dupont B, Erlich HA, et al. Nomenclature for factors of the HLA system, 2010. Tissue Antigens 2010;75:291-455.

Cano P, Klitz W, Mack SJ, Maiers M, Marsh SG, Noreen H, et al. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. Hum Immunol 2007;68:392-417.

Opelz G, Wujciak T, Dohler B, Scherer S, Mytilineos J. HLA compatibility and organ transplant survival. Collaborative Transplant Study. Rev Immunogenet 1999;1:334-42.

Takemoto S, Port FK, Claas FH, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol 2004;65:1489-505.

Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years’ experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000;343:1078-84.

Middleton D, Menchaca L, Rood H, Komerofsky R. New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 2003;61:403-7.

Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res 2011;39:D913-9.

Beatty PG, Boucher KM, Mori M, Milford EL. Probability of finding HLA-mismatched related or unrelated marrow or cord blood donors. Hum Immunol 2000;61:834-40.

Beatty PG, Mori M, Milford E. Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor. Transplantation 1995;60:778-83.

Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

Bodmer JG, Marsh SG, Albert ED, Bodmer WF, Bontrop RE, Charron D, et al. Nomenclature for factors of the HLA system, 1996. Eur J Immunogenet. 1997;24:105-51.

Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): An integrated software package for population genetics data analysis. Evol Bioinform 2005;1:47-50.

Sonnenberg FA, Eckman MH, Pauker SG. Bone marrow donor registries: the relation between registry size and probability of finding complete and partial matches. Blood 1989; 74:2569-78.

Muller CR, Ehninger G, Goldmann SF. Gene and haplotype frequencies for the loci hLA-A, hLA-B, and hLA-DR based on over 13,000 german blood donors. Hum Immunol 2003;64:137-51.

Red/Consejo Iberoamericano de Donación y Trasplante (RCIDT). Trasplante Iberoamérica. Newsletter Iberoamérica 2010;4:1-41.

Instituto Nacional de Salud (INS). Informe anual red de donación y trasplante de Colombia. Red de Trasplante. 2013:1-127.

Kwok J, Chan GS, Lam MF, Yan T, Tang L, Kwong KM, et al. Determination of mismatched donor HLA in kidney transplant recipients with unknown donor HLA phenotypes. Clin Transplant 2010;24:E178-81.

Rodríguez LM, Giraldo MC, García N, Velásquez L, París SC, Álvarez CM, et al. Human leucocyte antigen gene (HLA-A, HLA-B, HLA-DRB1) frequencies in deceased organ donors. Biomédica 2007;27: 537-47.

Ávila-Portillo LM, Carmona A, Franco L, Briceño I, Casas MC, Gómez A. Bajo polimorfismo en el sistema de antígenos de leucocitos humanos en población mestiza colombiana. Rev Universitas Med 2010;51:359-70.

Ossa H, Manrique A, Quintanilla S, Peña A. Polimorfismos del sistema HLA (loci A*, B* y DRB1*) en población colombiana. Rev Nova 2007;5:25-30.

Downloads

Download data is not yet available.

Similar Articles

<< < 1 2 3 4 5 6 7 8 > >> 

You may also start an advanced similarity search for this article.